GSK3B and bipolar disorder: The researchers further combined the knowledge of the known interaction between GSK-3β and WWOX [93], and after they confirmed over-activation of GSK-3β (dephosphorylation at Ser9) they used pre-treatment with lithium, a drug which is highly used for bipolar disorders [218] that also inhibits GSK-3β, to suppress PTZ-induced seizures.